J. Mark Braughler
No más puestos en curso
Historial de carrera de J. Mark Braughler
Antiguos cargos conocidos de J. Mark Braughler.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Director/Miembro de la Junta | - | 01/07/2013 |
PRECIGEN, INC. | Corporate Officer/Principal | - | - |
Formación de J. Mark Braughler.
University of Pittsburgh | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Health Technology | 2 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PRECIGEN, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Commercial Services |
- Bolsa de valores
- Insiders
- J. Mark Braughler
- Experiencia